Osteogenesis Imperfecta

Management of Genetic Syndromes: Third Edition

Volumn , Issue , 2010, Pages 597-614

  Marini, Joan C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bone fragility; Brittle bone disease; Bruisability; Osteogenesis imperfecta

Indexed keywords

EID: 84886053777     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470893159.ch40     Document Type: Chapter

References (61)

1. Antoniazzi F, Bertoldo F, Mottes M, Valli M, Sirpresi S, Zamboni G, Valentini R, Tato L (1996) Growth hormone treatment in osteo-genesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr 129:432-39.
2. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355:2757-2764.
3. Bateman JF, Golub SR (1994) Deposition and selective degradation of structurally abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. Matrix Biol 14:251-262.
4. Binder HB, Conway A, Hason S, Gerber LH, Marini JC, Berry R, Weintrob J (1993) Comprehensive rehabilitation of the child with osteogenesis imperfecta. Am J Med Genet 45:265-269.
5. Cabral WA, Marini JC (2004) High proportion of mutant osteo-blasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 74:752-760.
6. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007a) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39:359-365.
7. Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, Keene DR, Persikov AV, Leikin S, Marini JC (2007b) Y-position cysteine substitution in type I collagen (al(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype. Hum Mutat 28:396-405.
8. Camera G, Dodero D, De Pascale S (1983) Prenatal diagnosis of thanatophoric dysplasia at 24 weeks. Am J Med Genet 18:39-43.
9. Charnas LR, Marini JC (1993) Communicating hydrocephalus, basilar invagination and other neurologic features in osteogen-esis imperfecta. Neurology 43:2603-2608.
10. Cohn DH, Starman B J, Blumberg B, Byers PH (1990) Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1 Al). Am J Hum Genet 46:591-601.
11. Ekman O (1788) Dissertatio medica descriptionem et casus aliquot ostoemalaciae sistens. Uppsala.
12. Elejalde BR, de Elejalde MM (1985) Thanatophoric dysplasia: Fetal manifestations and prenatal diagnosis. Am J Med Genet 22:669-683.
13. Engelbert RHH, Helders PJM, Keessen W, Pruijs HE, Gooskens RHJM (1995) Intramedullary rodding in type III osteogenesis imperfecta: Effects on neuromotor development in 10 children. Acta Orthop Scand 66:361-364.
14. Engelbert RH, Gerver WJ, Breslau-Siderius LJ (1998) Spinal complications in osteogenesis imperfecta: 47 patients 1-16 years of age. Acta Orthop Scand 69:283-286.
15. Fedarko NS, Moerike M, Brenner R, Robey PG, Vetter U (1992) Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 7:921-929.
16. Fryns JP, van den Berghe K, van Assche A, van den Berghe H (1981) Prenatal diagnosis of campomelic dwarfism. Clin Genet 19:199-201.
17. Garretsen AJ, Cremers CW, Huygen PL (1997) Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I. Ann Otol Rhinol Laryngol 106:575-582.
18. Gerber LH, Binder H, Weintrob J, Grange DK, Shapiro J, Fromherz WF, Berry R, Conway A, Nason S, Marini JC (1990) Rehabilitation of children and infants with osteogenesis imperfecta. A program for ambulation. Clin Orthop Relat Res 251:254-262.
19. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclical administration of pamidronate therapy in chil-dren with severe osteogenesis imperfecta. N Engl J Med 339:947-952.
20. Glorieux FH, Rauch F, Plotkin H, Ward LM, Travers R, Roughley PJ, Lalic L, Glorieux DF, Fassier F, Bishop NJ (2000) Type V osteogenesis imperfecta: A new form of brittle bone disease. J Bone Miner Res 15:1650-1658.
21. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley P, Travers R (2002) Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30-38.
22. Hortop J, Tsipouras P, Hanley J, Maron B, Shapiro J (1986) Cardiovascular involvement in osteogenesis imperfecta. Circu-lation 73:54-61.
23. Kivirikko KI (1993) Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 25:113-126.
24. Kuivaniemi H, Tromp G, Prockop DJ (1997) Mutations in fibrillar collagens (types I, II, III and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage and blood vessels. Hum Mutat 9:300-315.
25. Kuurila K, Grenman R, Johansson R, Katitila I (2000) Hearing loss in children with osteogenesis imperfecta. Eur J Pediatr 159:515-519.
26. Levin LS, Salinas CF, Jorenson RJ (1978) Classification of osteo-genesis imperfecta by dental characteristics. Lancet 1:332.
27. Looser E (1906) Zur kenntnis der osteogenesis imperfecta congenita et tarda. Mitt Girenzgeb Med Chir 15:161.
28. Luhmann SJ, Sheridan JJ, Capelli AM, Schoenecker PL (1998) Management of lower extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: A twenty year experience. J Pediatr Orthop 18:88-94.
29. Lund AM, Jensen BL, Nielson LA, Skovby F (1998) Dental manifestations of osteogenesis imperfecta and abnormalities of collagen metabolism. J Craniofac Genet Dev Biol 18:30-37.
30. Malfait F, Symoens S, De Backer J, Hermanns-LeT, Sakalihasan N, Lapiere CM, Coucke P, De Paepe A (2007) Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat 28:387-395.
31. Marini JC (2006) Should children with osteogenesis imperfecta be treated with bisphosphonates?. Nat Clin Pract Endocrinol Metab 2:14-15.
32. Marini JC, Gerber NL (1997) Osteogenesis imperfecta: Rehabilita-tion and prospects for gene therapy. JAMA 277:746-750.
33. Marini JC, Bordenick S, Heavner G, Rose S, Chrousos GP (1993a) Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta. Am J Med Genet 45:261-264.
34. Marini JC, Bordenick S, Heavner G, Rose S, Hintz R, Rosenfeld R, Chrousos GP (1993b) The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 76:251-256.
35. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Korkko J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Daigleish R, Byers PH (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209-221.
36. Marini JC, Cabral WA, Barnes AM, Chang W (2007) Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle 6:1675-1681.
37. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291-304.
38. McKusick VA (1972) Osteogenesis imperfecta. In: Heritable Dis-orders of Connective Tissue, 4th ed. St. Louis, MO: Mosby.
39. O'Connell AC, Dent B, Marini JC (1999) Evaluation of oral problems in an osteogenesis imperfecta population. Oral Surg Oral Med Oral Pathol 87:189-196.
40. Pedersen U (1984) Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients. Scand Audiol 13:67-74.
41. Pepin M, Atkinson M, Starman BJ, Byers PH (1997) Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: A review of biochemical and molecular studies completed in 129 pregnancies. Prenat Diagn 17:559-570.
42. Plotkin H, Rauch F, Bishop NJ, Monpetit K, Ruck-Gibis J, Travers R, Glorieux FH (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 85:1846-1850.
43. Porat S, Heller E, Seidman DS, Meyer S (1991) Functional results of operation in osteogenesis imperfecta: Elongating and nonelon-gating rods. J Pediatr Orthop 11:200-203.
44. Prockop DJ (1997) What holds us together? Why do some of us fall apart? What can we do about it?. Matrix Biol 16:519-528.
45. Ranta H, Lukinmaas P, Waltimo J (1993) Heritable dentin defects: Nosology, pathology and treatment. Am J Med Genet 45:193-200.
46. Sarafova AP, Choi H, Forlino A, Gajko A, Cabral WA, Tosi L, Reing CM, Marini JC (1998) Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen. Hum Mutat 11:395-103.
47. Sawin PD, Menezes AH (1997) Basilarinvagination in osteogenesis imperfecta and related osteochondrodysplasias: Medical and surgical management. J Neurosurg 86:950-960.
48. Sillence DO (1981) Osteogenesis imperfecta: An expanding pano-rama of variants. Clin Orthop Relat Res 159:11-25.
49. Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101-116.
50. Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL (1984) Osteogenesis imperfecta type II: Delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 17:407.
51. Sillence DO, Barlow KK, Cole WG, Dietrich S, Garber AP, Rimoin DL (1986) Osteogenesis type III: Delineation of phenotype with reference to genetic heterogeneity. Am J Med Genet 23:821.
52. Sillence D, Butler B, Latham M, Barlow K (1993) Natural history of blue sclerae in osteogenesis imperfecta. Am J Med Genet 45:183-186.
53. Superti-Furga A (1996) Achondrogenesis type IB. J Med Genet 33:957-961.
54. Thompson EM (1993) Non-invasive prenatal diagnosis of osteo-genesis imperfecta. Am J Med Genet 45:201-206.
55. Van der Hoeve J, de Kleyn A (1918) Blaue sclerae, knochenbru-chigkeit und schwerhorigkeit. Arch Ophthalmol 95:81.
56. Vetter U, Maierhofer B, Muller M, Teller W, Brenner R, Frohne-berg D, Wordsdorfer O (1989) Osteogenesis imperfecta in childhood: Cardiac and renal manifestations. Eur J Pediatr 149:184-187.
57. Vrolik W (1849) Tabulae ad illustrandam embryogenesium hominis et mammalium tarn naturalem quam abnormen. Amsterdam.
58. Whyte MP (1995) Hypophosphatasia. In: The Metabolic Basis of Inherited Diseases, Scriver CR, Beaudet AL, Sly WS, Valle D, eds, New York: McGraw Hill, Inc., Chapter 136, pp. 4095-111.
59. Williams JD (1998) In: Textbook of Endocrinology, Wilson, Foster DW, Kronenberg HK, Larsen PR, eds, (9th ed.) Philadelphia, PA: Saunders, pp. 1221-1228.
60. Willing MC, Pruchno CJ, Byers PH (1993) Molecular heteroge-neity in osteogenesis imperfecta type I. Am J Med Genet 45:223-227.
61. Zionts LE, Edward A, Stott NS (1998) Complications in the use of the Bailey-Dubow extensible nail. Clin Orthop Relat Res 348:186-195.